Open Access Open Access  Restricted Access Subscription or Fee Access

Aberrant behaviors in a primary care-based cohort of patients with chronic pain identified as misusing prescription opioids

Martin D. Cheatle, PhD, Charles P. O’Brien, MD, PhD, Koshy Mathai, MD, Matthew Hansen, MD, Mario Grasso, MD, Peter Yi, MD

Abstract


Objective: To assess aberrant drug-related behaviors (ADRBs) in patients discharged from a community primary care practice for opioid misuse and treating physician’s ability to identify predictive aberrant behaviors.

Design: Retrospective chart review of patients with chronic noncancer pain (CNCP) identified by their treating physician as misusing opioid analgesics, and patients with similar characteristics who had not been identified as misusing opioids. A survey of attending and resident physicians from these clinics on their knowledge of ADRBs was also collected.

Setting: Community primary care clinic.

Patients, participants: Thirty-three patients with CNCP identified by their treating physician as misusing prescription opioid analgesics, and 33 patients randomly selected from the same clinic setting, with similar characteristics who had not been identified as misusing opioids. Twenty-four attending physicians and 42 resident physicians were surveyed on their training and knowledge of predictive aberrant behaviors.

Results: More identified misusers than nonmisusers reported positive history of substance abuse (p = 0.001), tobacco use (p = 0.011), taking multiple doses of prescribed opioids together (0.024), multiple complaints of pain requiring opioid treatment (p = 0.006), and multiple phone calls to the clinic requesting opioid medications (p = 0.027). Logistic regression on continuous variables revealed that only the number of phone calls to the clinic regarding opioids in the last 12 months achieved significance (p = 0.028).

Conclusions: Previously postulated and novel ADRBs suggestive of opioid misuse were identified in a community primary care setting. Differences in resident and attending physician’s ability to identify key predictive ADRBs and lack of training in pain or addiction underscores the need for changes in medical school and residency programs.


Keywords


aberrant drug-related behaviors, chronic noncaner pain, opioids, primary care

Full Text:

PDF

References


Warner M, Chen LH, Makuc DM: Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. NCHS Data Brief. 2009; 22: 1-8.

Paulozzi LJ, Budnitz DS, Xi Y: Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006; 15: 618-627.

Paulozzi LJ, Ryan GW: Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006; 31(6): 506-511.

Bohnert AS, Valenstein M, Bair MJ, et al.: Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305(13): 1315-1321.

Birnbaum HG, White AG, Schiller M, et al.: Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011; 12(4): 657-667.

Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality: Treatment Episode Data Set (TEDS): 2000-2010. National Admissions to Substance Abuse Treatment Services. DASIS Series S-61, HHS Publication No. (SMA) 12-4701. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2012.

Katz N, Sherburne S, Beach M, et al.: Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003; 97(4): 1097-1102.

Martell BA, O’Connor PG, Kerns RD, et al.: Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med. 2007; 146(2): 116-127.

Ballantyne JC, LaForge KS: Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 2007; 129(3): 235-255.

Webster LR, Webster RM: Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Med. 2005; 6: 432-442.

Fleming M, Davis J, Passik S: Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med. 2008; 9(8): 1098-1106.

Compton P, Darakjian J, Miotto K: Screening for addiction in patients with chronic pain and “problematic” substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage. 1998; 16(6): 355-363.

Michna E, Ross EL, Hynes WL, et al.: Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage. 2004; 28(3): 250-258.

Passik SD, Kirsh KL, Donaghy KB, et al.: Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006; 22(2): 173-181.

Portenoy RK: Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage. 1996; 11(4): 203-217.

Passik SD, Kirsh KL, Whitcomb L, et al.: A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004; 26(4): 552-561.

American Pain Society: Definitions related to the use of opioids for the treatment of pain. A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. I. Glenview, The American Academy of Pain Medicine, 2001.

Savage SR: Assessment for addiction in pain-treatment settings. Clin J Pain. 2002; 18(4 suppl): S28-S38.

Reid MC, Engles-Horton LL, Weber MB, et al.: Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002; 17(3): 173-179.

Adams NJ, Plane MB, Fleming MF, et al.: Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001; 22: 791-796.

Manchikanti L, Damron KS, McManus CD, et al.: Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study. Pain Physician. 2004; 7(4): 431-437.

Mahowald ML, Singh JA, Majeski P: Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum. 2005; 52(1): 312-321.

Ready LB, Sarkis E, Turner JA: Self-reported vs. actual use of medications in chronic pain patients. Pain. 1982; 12(3): 285-294.

Breuer B, Cruciani R, Portenoy RK: Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: A national survey. South Med J. 2010; 103(8): 738-747.

Upshur CC, Luckmann RS, Savageau JA: Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med. 2006; 21(6): 652-655.

Ives TJ, Chelminski PR, Hammett-Stabler CA, et al.: Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res. 2006; 6: 46.

Edlund MJ, Steffick D, Hudson T, et al.: Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007; 129(3): 355-362.

Turk DC, Swanson KS, Gatchel RJ: Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain. 2008; 24(6): 497-508.

Novy DM, Lam C, Gritz ER, et al.: Distinguishing features of cancer patients who smoke: Pain, symptom burden, and risk for opioid misuse. J Pain. 2012; 13(11): 1058-1067.




DOI: https://doi.org/10.5055/jom.2013.0174

Refbacks

  • There are currently no refbacks.